Taking people in Franciaország1. fázis
First-In-Human study evaluating the Safety of administration of ABD-3001 to Patients with Relapsed/Refractory Acute Myeloid Leukemia or High/Very-high Risk Myelodysplastic Syndromes
Key facts
- Where
- Marseille, Montpellier Cedex 5, Nice, Paris és Pierre-Bénite, FranciaországSee the 5 sites
- Phase
- 1. fázis
Where in Franciaország
- Centre Hospitalier Regional De MarseilleMarseille, FranciaországTaking people
- Centre Hospitalier Universitaire De MontpellierMontpellier Cedex 5, FranciaországTaking people
- Centre Hospitalier Universitaire de NiceNice, FranciaországTaking people
- Hopital Saint LouisParis, FranciaországTaking people
- Hospices Civils de LyonPierre-Bénite, FranciaországTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Advanced Biodesign
- Trial code
- EU 2024-518813-24-00
- Record updated
- 2026. március 18.